Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic Acid Delta-lactone
1. 5119-48-2
2. Withaferine A
3. Nsc 273757
4. Withaferin Deriv Jpr, Iowa U. Compound
5. Nsc-101088
6. Nsc101088
7. L6do3qw4k5
8. Ashwagandha
9. Chebi:69120
10. Nsc-273757
11. 4beta,27-dihydroxy-1-oxo-5beta,6beta-epoxywitha-2,24-dienolide
12. (1s,2r,6s,7r,9r,11s,12s,15r,16s)-6-hydroxy-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
13. (6s,7r,9r)-6-hydroxy-15-[(2r,3r)-3-hydroxy-4-(4-methyl-5-oxo-2h-furan-3-yl)butan-2-yl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
14. (4beta,5beta,6beta,22r)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
15. Unii-l6do3qw4k5
16. Brn 1335150
17. 5.beta.-ergosta-2, 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo-, .delta.-lactone, (20s,22r)-
18. Ergosta-2, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,22r)-
19. Nsc 101088
20. Withaferin A [mi]
21. 5-19-06-00604 (beilstein Handbook Reference)
22. Mls006010687
23. Schembl157208
24. Chembl517080
25. Withaferin A, Analytical Standard
26. Withaferin A, >=95% (hplc)
27. Hy-n2065
28. Zinc8234189
29. Mfcd10687098
30. Nsc273757
31. S8587
32. Ncgc00180796-02
33. (4beta,5beta,6beta,22r)-5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic Acid, Delta-lactone
34. 5-beta-ergosta-2,24-dien-26-oic Acid, 5,6-beta-epoxy-4-beta,22,27-trihydroxy-1-oxo-, Delta-lactone, (20s,22r)-
35. 5beta-ergosta-2,24-dien-26-oic Acid, 5,6beta-epoxy-4beta,22,27-trihydroxy-1-oxo-, Delta-lactone, (20s,22r)-
36. As-77575
37. Ergosta-2,24-dien-26-oic Acid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, Gamma-lactone, (4bta,5beta,6beta,22r)-
38. Nci60_000031
39. Smr004701668
40. B7199
41. Cs-0018562
42. Withaferin A 100 Microg/ml In Acetonitrile
43. C08841
44. A871350
45. A1-06845
46. Q6606395
47. Brd-k88378636-001-01-0
48. Withaferin A (constituent Of Ashwagandha Root) [dsc]
49. Wln: T3 F5 E666 1a R Axo Ov Pu Ch&ttttj J1 N1 Rq Iy1&- Ft6ov Cutj C1q D1
50. (4.beta.,5.beta.,6.beta.,22r)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
51. Ergosta-2,24-dien-26-oicacid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, D-lactone, (4b,5b,6b,22r)-
52. Ncgc00180796-02_c28h38o6_(4beta,5beta,6beta,22r)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
| Molecular Weight | 470.6 g/mol |
|---|---|
| Molecular Formula | C28H38O6 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 470.26683893 g/mol |
| Monoisotopic Mass | 470.26683893 g/mol |
| Topological Polar Surface Area | 96.4 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 999 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34060
Submission : 2019-08-10
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ashwagandha manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ashwagandha, including repackagers and relabelers. The FDA regulates Ashwagandha manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ashwagandha API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ashwagandha manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ashwagandha supplier is an individual or a company that provides Ashwagandha active pharmaceutical ingredient (API) or Ashwagandha finished formulations upon request. The Ashwagandha suppliers may include Ashwagandha API manufacturers, exporters, distributors and traders.
click here to find a list of Ashwagandha suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ashwagandha DMF (Drug Master File) is a document detailing the whole manufacturing process of Ashwagandha active pharmaceutical ingredient (API) in detail. Different forms of Ashwagandha DMFs exist exist since differing nations have different regulations, such as Ashwagandha USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ashwagandha DMF submitted to regulatory agencies in the US is known as a USDMF. Ashwagandha USDMF includes data on Ashwagandha's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ashwagandha USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ashwagandha suppliers with USDMF on PharmaCompass.
Ashwagandha Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ashwagandha GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ashwagandha GMP manufacturer or Ashwagandha GMP API supplier for your needs.
A Ashwagandha CoA (Certificate of Analysis) is a formal document that attests to Ashwagandha's compliance with Ashwagandha specifications and serves as a tool for batch-level quality control.
Ashwagandha CoA mostly includes findings from lab analyses of a specific batch. For each Ashwagandha CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ashwagandha may be tested according to a variety of international standards, such as European Pharmacopoeia (Ashwagandha EP), Ashwagandha JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ashwagandha USP).
LOOKING FOR A SUPPLIER?
